United States · FDA National Drug Code directory
INLEXZO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-225_3e9075cb-001f-40f0-e063-6394a90aee94
- Product NDC
- 57894-225
- Form
- SYSTEM
- Composition / generic term
- gemcitabine intravesical
- Labeler
- Janssen Biotech, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250914
- Source listing expiry
- 20261231
Source-listed ingredients
- GEMCITABINE — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYSTEM in 1 BOX (57894-225-01) · 57894-225-01
- 1 SYSTEM in 1 BOX (57894-225-99) · 57894-225-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →